NextCure, Inc.NXTCNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank38
3Y CAGR-16.4%
5Y CAGR-5.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-16.4%/yr
vs +58.9%/yr prior
5Y CAGR
-5.7%/yr
Recent deceleration
Acceleration
-75.3pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $12.69M | -19.3% |
| 2024 | $15.72M | -20.2% |
| 2023 | $19.71M | -9.2% |
| 2022 | $21.71M | +5.5% |
| 2021 | $20.57M | +20.7% |
| 2020 | $17.05M | +77.4% |
| 2019 | $9.61M | +182.0% |
| 2018 | $3.41M | +31.4% |
| 2017 | $2.60M | - |